JPRN-UMIN000018835已完成未知
Exploratory clinical trial of the new third line Helicobacter pylori eradication therapy using vonoprazan - Efficacy of the new third line Helicobacter pylori eradication therapy using vonoprazan
Department of Gastroenterology, The University of Tokyo0 个研究点目标入组 120 人开始时间: 2015年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy Lactation Allergy for the study drugs Severe major organ dysfunction Patients who are judged by the investigators to be inappropriate for this study
研究者
相似试验
已完成
不适用
Exploratory clinical trial of the new 4th line Helicobacter pylori eradication therapy using vonoprazaHelicobacter infection with previous eradication failureJPRN-UMIN000018836Department of Gastroenterology, The University of Tokyo30
进行中（未招募）
不适用
Phase III clinical trial comparing treatments of hormone-refractory prostate cancer (HRPC) with Docetaxel: continuous treatment vs. intermittent repetition of treatment after progression. - PRINCEEUCTR2005-001602-76-DECharité - Universitätsmedizin Berlin
进行中（未招募）
1 期
International cooperative Phase III trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children and adolescents < 18 years.EUCTR2013-004187-56-DEGeorg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen167
招募中
3 期
International cooperative Phase III trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children and adolescents < 18 years.brain tumorshigh grade gliomadiffuse intrinsic pontine glioma10029211gliomatosis cerebriNL-OMON54159Georg-August-Universität Göttingen20
招募中
3 期
International cooperative Phase III trial of the HIT-HGG study groupfor the treatment of high grade glioma, diffuse intrinsic pontine glioma, andgliomatosis cerebri in children and adolescents < 18 years.Glioblastoma WHO grade IV (Giant cell glioblastoma, Epitheloid Glioblastoma, Glioblastoma IDH-wildtype, Glioblastoma NOS, Gliosarcoma, Glioblastoma IDH-mutant)(9441/3, 9440/3, 9442/3, 9445/3*) Diffuse midline glioma H3 K27M-mutant (9385/3*)Anaplastic astrocytoma WHO Grad III (IDH mutant, IDH-wildtype, NOS) (9401/3) Diffuse intrinsic pontine glioma (9385/3)Gliomatosis cerebri (9381/3)DRKS00012806niversitätsmedizin Göttingen167